Immunotherapy has dramatically improved the treatment outcomes of primary lung cancer; however, it sometimes causes a serious side effect called interstitial lung disease.
Covered recently in the prestigious journal Nature Medicine, BiomedGPT is a new a new type of artificial intelligence (AI) designed to support a wide range of medical and scientific tasks.
The study was conducted with 50 U.S.-licensed physicians in family medicine, internal medicine and emergency medicine.
The computational tool is called PIONEER (Protein-protein InteractiOn iNtErfacE pRediction). Researchers demonstrated PIONEER's utility by identifying potential drug targets for dozens of cancers and other complex diseases in a recently published Nature Biotechnology article.
In a test whose results were published today, the video system recognized and identified, with high proficiency, which medications were being drawn in busy clinical settings.